Kainos Laboratories

Kainos Laboratories EBIT Margin

Delisted

The EBIT Margin (Operating Margin) of Kainos Laboratories (4556.T) as of Oct 29, 2026 is 15.52 %. In the previous year, EBIT Margin (Operating Margin) was 17.11 % — a change of -9.28% (lower).

EBIT Margin

15.52 %

YoY

-9.28%

Last updated:

EBIT Margin (Operating Margin) of Kainos Laboratories is 2025 15.52 % . EBIT Margin (Operating Margin) of Kainos Laboratories was 2024 17.11 % . It decreases by -9.28% lower compared to the previous year.

Kainos Laboratories's operating (EBIT) margin stands at 15.5%, broadly stable from 14.9% several years earlier.

The Kainos Laboratories EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
10.40 JPY
Jan 1, 2019
12.44 JPY
Jan 1, 2020
13.21 JPY
Jan 1, 2021
14.85 JPY
Jan 1, 2022
16.20 JPY
Jan 1, 2023
16.68 JPY
Jan 1, 2024
17.11 JPY
Jan 1, 2025
15.52 JPY
The Kainos Laboratories EBIT Margin history
YEAREBIT MarginYoY
15.52 %-9.28%
17.11 %+2.60%
16.68 %+2.93%
16.20 %+9.11%
14.85 %+12.43%
13.21 %+6.14%
12.44 %+19.61%
10.40 %+3.05%
10.10 %+21.99%
8.28 %+12.90%
7.33 %+33.64%
5.48 %+11,923.05%
0.05 %+2.22%
0.04 %-8.16%
0.05 %-1.80%
0.05 %+617.37%
0.01 %-48.84%
0.01 %-36.88%
0.02 %-37.62%
0.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kainos Laboratories Stock analysis

What does Kainos Laboratories do? Kainos Laboratories Inc develops and manufactures pharmaceuticals, diagnostic reagents, and related chemical products for distribution and import/export. The company sells its products to healthcare providers, hospitals, and medical institutions within Japan and internationally. Its core offerings include prescription medications, diagnostic tools, and chemical compounds used in medical research and treatment. The business model relies on direct sales to medical facilities and global trade of its pharmaceutical and diagnostic solutions. Kainos Laboratories Inc focuses on the Japanese market with its headquarters in Bunkyo-Ku, Tokyo-To, while also engaging in international import/export activities. The company's revenue streams come from the sale of pharmaceuticals, diagnostic reagents, and chemical products to healthcare professionals and institutions. Its product portfolio targets medical practitioners and research organizations requiring specialized diagnostic and therapeutic solutions. The company operates with 144 full-time employees dedicated to the development, manufacturing, and distribution of its products. Kainos Laboratories Inc generates income through the commercialization of its pharmaceuticals and diagnostic reagents, serving both domestic and global clients in the healthcare sector. Sales are driven by demand for medical treatments and diagnostic tools in clinical and research settings. Kainos Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kainos Laboratories stock

EBIT Margin (Operating Margin) of Kainos Laboratories is 15.52 % in 2025.

EBIT Margin (Operating Margin) of Kainos Laboratories changed from 17.11 % to 15.52 %, representing a -9.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Kainos Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Kainos Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Kainos Laboratories

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Kainos Laboratories